argenx Analyst Price Targets - Benzinga

argenx SE

ARGXNASDAQ

Trade with Public

Trade with Public

$1023.21

-35.69-3.37%

가까이에: Aug 28, 5:00 PM EST

$1023.21

N/A

시간외: Aug 28, 4:00 PM EST

인수합병: Forte Biosciences (FBRX) was acquired by argenx (ARGX) on Thursday, August 27, 2026

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 주식 보고서

argenx Analyst Price Targets

Wall Street analyst price targets and consensus rating for argenx (ARGX).

Price Target Range — 8 Quarters

Analyst Consensus — 20 Analysts

2S.Buy

17Buy

1Hold

Consensus RatingBuy# Analysts20Avg. Consensus PT$1083Upside to Avg. PT+5.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 26, 2026	UBS	Xian Deng	Upgrade	Neutral→Buy	$960→$1400
Aug 26, 2026	Wells Fargo	Derek Archila	PT Raise	Overweight	$1350→$1415
Aug 18, 2026	Truist Securities	Danielle Brill	PT Raise	Buy	$1030→$1095
Aug 18, 2026	Morgan Stanley	Sean Laaman	PT Raise	Overweight	$1200→$1230
Aug 18, 2026	RBC Capital	Luca Issi	PT Raise	Outperform	$1025→$1100
Aug 18, 2026	Citizens	Jason N. Butler	PT Raise	Market Outperform	$932→$1200
Aug 18, 2026	Wedbush	David Nierengarten	PT Raise	Outperform	$1050→$1150
Aug 18, 2026	HC Wainwright & Co.	Douglas Tsao	PT Raise	Buy	$940→$1202
Aug 17, 2026	Piper Sandler	Allison Bratzel	PT Raise	Overweight	$1075→$1215
Aug 5, 2026	Guggenheim	Yatin Suneja	Reinstates	Buy	$1185
Jul 28, 2026	Wedbush	David Nierengarten	PT Raise	Outperform	$1000→$1050
Jul 27, 2026	Baird	Colleen Kusy	PT Raise	Neutral	$867→$932
Jul 24, 2026	Oppenheimer	Leland Gershell	PT Raise	Outperform	$1014→$1037
Jul 24, 2026	RBC Capital	Luca Issi	PT Raise	Outperform	$945→$1025
Jul 24, 2026	Guggenheim	Yatin Suneja	PT Raise	Buy	$1135→$1185
Jul 24, 2026	Citizens	Jason N. Butler	PT Cut	Market Outperform	$944→$932
Jul 21, 2026	Citigroup	Samantha Semenkow	PT Raise	Buy	$1152→$1182
Jul 7, 2026	RBC Capital	Luca Issi	PT Raise	Outperform	$890→$945
Jul 2, 2026	B of A Securities	Tazeen Ahmad	PT Raise	Buy	$1016→$1088
Jun 25, 2026	HC Wainwright & Co.	Douglas Tsao	Maintained	Buy	$940

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Upgrades argenx to Buy, Raises Price Target to $1400

UBS analyst Xian Deng upgrades argenx (NASDAQ:ARGX) from Neutral to Buy and raises the price target from $960 to $1400.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on argenx, Raises Price Target to $1415

Wells Fargo analyst Derek Archila maintains argenx (NASDAQ:ARGX) with a Overweight and raises the price target from $1350 to $1415.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on argenx, Raises Price Target to $1095

Truist Securities analyst Danielle Brill maintains argenx (NASDAQ:ARGX) with a Buy and raises the price target from $1030 to $1095.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on argenx, Raises Price Target to $1100

RBC Capital analyst Luca Issi maintains argenx (NASDAQ:ARGX) with a Outperform and raises the price target from $1025 to $1100.

Benzinga Newsdesk

Snowflake To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwright & Co raised the price target for argenx SE - ADR (NASDAQ: ARGX) from $940 to $1,202. Goldman Sachs boosted PBF Energy Inc (NYSE: PBF) price target from $71 to $81. B of A Securities increased price target for Americold Realty Trust Inc (NYSE: COLD) from $15 to $16.

Avi Kapoor

These Analysts Boost Their Forecasts On Argenx

Argenx SE (NASDAQ:ARGX) reports positive Phase 3 results for VYVGART Hytrulo in autoimmune myositis. Analysts raise price targets on ARGX stock.

Avi Kapoor